<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   COVID-19: Epidemiology, clinical features, and prognosis of the critically ill adult
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       COVID-19: Epidemiology, clinical features, and prognosis of the critically ill adult
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        COVID-19: Epidemiology, clinical features, and prognosis of the critically ill adult
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George L Anesi, MD, MSCE, MBE
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott Manaker, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allyson Bloom, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 18, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H345377203">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A proportion of patients with coronavirus disease 2019 (COVID-19) can become critically ill due to either the development of acute respiratory distress syndrome (ARDS) or complications of the disease itself.
        </p>
        <p>
         This topic will discuss the epidemiology, clinical features, and prognosis of adult patients who become critically ill with COVID-19. General clinical features of patients with COVID-19 and management of the critically ill nonintubated and intubated patient with COVID-19 are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127419.html" rel="external">
          "COVID-19: Management of the intubated adult"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/131226.html" rel="external">
          "COVID-19: Respiratory care of the nonintubated hypoxemic adult (supplemental oxygen, noninvasive ventilation, and intubation)"
         </a>
         .)
         <span class="utd-adt-cnt utd-adt-pathwys utd-content-128064">
          (Related Pathway(s):
          <a class="utd-content-128064" href="/pathway/128064?topicRef=131224&amp;source=see_link">
           COVID-19: Anticoagulation in adults with COVID-19
          </a>
          .)
         </span>
        </p>
        <p class="headingAnchor" id="H2237889370">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reports during the initial phase of the pandemic suggest that among those with COVID-19, up to 20 percent develop severe disease requiring hospitalization [
         <a href="#rid1">
          1-9
         </a>
         ]. Among those who are hospitalized, up to one-quarter need intensive care unit (ICU) admission, representing approximately 5 to 8 percent of the total infected population [
         <a href="#rid2">
          2,3,8-17
         </a>
         ]. The spectrum of severity and case fatality rates associated with COVID-19 are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Spectrum of severity and fatality rates'
         </a>
         .)
        </p>
        <p>
         Rates of ICU admission vary. Differences in the rates of ICU admission may relate to local, cultural, and geographic differences in practice and admission criteria for ICU as well as differences in population characteristics within the region served by the ICU. For example, among cohorts from China, rates of ICU admission in hospitalized patients ranged from 7 to 26 percent [
         <a href="#rid2">
          2,3,8,10
         </a>
         ]. Similarly, the proportion of ICU admissions in Italy were between 5 and 12 percent, representing 16 percent of all hospitalized patients [
         <a href="#rid11">
          11,12
         </a>
         ]. In the US and Canada, rates of ICU admission have ranged from 5 to 81 percent [
         <a href="#rid9">
          9,13,14,18
         </a>
         ].
        </p>
        <p>
         Admission rates to the ICU may be decreasing as the pandemic progresses [
         <a href="#rid15">
          15,19,20
         </a>
         ]. In an analysis of a second surge in Houston, Texas, a smaller proportion of hospitalized patients were admitted to the ICU compared with the first surge (20 versus 38 percent) [
         <a href="#rid15">
          15
         </a>
         ]. The reasons for this are unclear but may include increased adherence to prevention strategies, the development of new therapies, increased comfort with respiratory management outside of the ICU (eg, increased use of noninvasive respiratory support), and altered demographics of infected populations (eg, younger population) [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p>
         Since vaccination is effective at preventing severe disease and death, admission rates to the ICU are likely lower in the United States [
         <a href="#rid21">
          21,22
         </a>
         ]. However, the impact of new viral strains that have the potential for increased virulence is unknown and is under continued investigation. (See
         <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">
          "COVID-19: Vaccines"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126981.html" rel="external">
          "COVID-19: Epidemiology, virology, and prevention", section on 'Virology'
         </a>
         .)
        </p>
        <p>
         Males have comprised a disproportionately high number of critical cases in multiple cohorts worldwide (up to three-quarters in early cohorts from China) [
         <a href="#rid10">
          10,16,17
         </a>
         ]; however, some cohort studies have suggested a more even proportion of critically ill men and women [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
         Patients in select racial or ethnic minority population may also have a higher risk of severe disease including high rates of hospitalization, ICU admission, and mortality [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3449960210">
         <span class="h1">
          CLINICAL FEATURES IN CRITICALLY ILL PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Discussion in this section is limited to clinical features in those who are critically ill. General clinical features of COVID-19 patients are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2091959514">
         <span class="h2">
          Rate and risk of progression to critical illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retrospective studies of critically ill patients have suggested that among patients who develop critical illness (ie, acute respiratory distress syndrome [ARDS]), onset of dyspnea is relatively late (median 6.5 days after symptom onset), but progression to ARDS can be swift thereafter (median 2.5 days after onset of dyspnea) [
         <a href="#rid2">
          2,3,13,25-27
         </a>
         ].
        </p>
        <p>
         Age appears to be the major risk factor that predicts progression to ARDS [
         <a href="#rid5">
          5,13,14,27,28
         </a>
         ]. Others include comorbidities (eg, obesity, hypertension, metabolic syndrome), male sex, socioeconomic background, high fever (≥39°C), blood type, and select laboratory and viral features. These risk factors are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Risk factors for severe illness'
         </a>
         .)
        </p>
        <p>
         For patients with COVID-19 who are critically ill and admitted to the ICU, the length of stay is often prolonged (eg, one to four weeks), unless the reason for admission is for an acute issue that is rapidly reversible (eg, rapid atrial fibrillation, heart failure, hypovolemia). (See
         <a class="local">
          'Length of stay'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4246586151">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who later become critically ill with COVID-19 may present with similar initial respiratory symptoms to those with less severe illness (eg, fever, cough, dyspnea) (see
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features"
         </a>
         ). Specifically, among those who are critically ill:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Profound acute hypoxemic respiratory failure from ARDS is the dominant finding [
         <a href="#rid1">
          1-3,13,16,17,26,28-36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypercapnia is rare (unless associated with, for example, a chronic obstructive pulmonary disease exacerbation or narcotic overdose).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fevers tend to wax and wane during ICU admission, particularly in the first few days to week.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The need for mechanical ventilation among those who are critically ill and admitted to the ICU ranges from 20 to 100 percent [
         <a href="#rid2">
          2,9,13,14,16-18,28,31,36
         </a>
         ]. The wide range likely reflects differences in practice, criteria for intubation, and populations served by the ICU. A small proportion require extracorporeal membrane oxygenation. Data suggest decreased rates of mechanical ventilation over time [
         <a href="#rid37">
          37
         </a>
         ], which may be due to changes in patient- and/or practice-level factors.
        </p>
        <p>
        </p>
        <p>
         Patients may also present with features associated with complications of COVID-19 (eg, dehydration and hypovolemia, delirium, stroke, venous thromboembolism, arrhythmia, acute myocardial infarction, heart failure, low urine output from acute renal insufficiency). (See
         <a class="local">
          'Complications'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Acute course and complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1854070084">
         <span class="h1">
          COMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Common complications of COVID-19-related acute respiratory distress syndrome (ARDS) include acute kidney injury (AKI), elevated liver enzymes, delirium/encephalopathy, cardiac injury (eg, cardiomyopathy, arrhythmia, and sudden cardiac death), and thrombosis [
         <a href="#rid38">
          38-42
         </a>
         ]. As an example, in a single-center retrospective cohort from China of 52 critically ill patients with COVID-19, complications included AKI (29 percent; half of whom needed renal replacement therapy), liver dysfunction (29 percent), and cardiac injury (23 percent) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3301945165">
         <span class="h2">
          Acute kidney injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         AKI is common among critically ill patients with COVID-19, and a proportion of those require renal replacement therapy (eg, 15 to 30 percent) [
         <a href="#rid18">
          18,40
         </a>
         ]. As an example, in one New York cohort of critically ill patients, one-third required renal replacement therapy for AKI [
         <a href="#rid40">
          40
         </a>
         ]. Further details are provided elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/127552.html" rel="external">
          "COVID-19: Issues related to acute kidney injury, glomerular disease, and hypertension", section on 'Acute kidney injury'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H768748980">
         <span class="h2">
          Gastrointestinal complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastrointestinal complications also appear to be more common in patients with ARDS from COVID-19 compared with patients who have ARDS for other reasons (74 versus 37 percent) [
         <a href="#rid43">
          43
         </a>
         ]. These include elevated aminotransferases (55 percent), severe ileus (48 percent), and mesenteric ischemia (4 percent). Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/129171.html" rel="external">
          "COVID-19: Gastrointestinal symptoms and complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1123804823">
         <span class="h2">
          Neurologic complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neurologic complications in critically ill patients are common [
         <a href="#rid44">
          44-48
         </a>
         ]. Among critically ill patients, delirium or encephalopathy is the most common complication and manifests with prominent agitation and confusion along with corticospinal tract signs (hyperreflexia). Consistent with this, intensivists have observed that sedation requirements are high in this population, particularly immediately after intubation. Other common complications include acute ischemic stroke, myositis, Guillain-Barré, and focal neuropathy. Encephalitis is rare [
         <a href="#rid47">
          47
         </a>
         ]. The neurologic complications of COVID-19 are described in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/128153.html" rel="external">
          "COVID-19: Neurologic complications and management of neurologic conditions"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1178475687">
         <span class="h2">
          Cardiac injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among critically ill patients, cardiac injury may be a complication that is concurrent with the respiratory illness, or a late complication, developing after the respiratory illness improves. (See
         <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">
          "COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"
         </a>
         .)
        </p>
        <p>
         A high rate of cardiomyopathy was noted among critically ill patients with COVID-19 in one United States cohort (33 percent) in Washington state [
         <a href="#rid13">
          13
         </a>
         ]. In another New York City cohort, cardiac complications among mechanically ventilated patients included atrial arrhythmias (18 percent), myocardial infarction (8 percent), and heart failure (2 percent) [
         <a href="#rid30">
          30
         </a>
         ]. One case series reported five patients who developed acute cor pulmonale, most of which occurred in association with hemodynamic instability or cardiac arrest [
         <a href="#rid49">
          49
         </a>
         ]. Another study reported that 14 percent of critically ill patients with COVID-19 had a cardiac arrest, with age and comorbidities as risk factor s [
         <a href="#rid50">
          50
         </a>
         ]. In a Philadelphia cohort, among 700 patients with COVID-19, there were 9 cardiac arrests, all of which occurred in the ICU [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         Cardiac complications of COVID-19 are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/127551.html" rel="external">
          "COVID-19: Arrhythmias and conduction system disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127533.html" rel="external">
          "COVID-19: Myocardial infarction and other coronary artery disease issues"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129342.html" rel="external">
          "COVID-19: Cardiac manifestations in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1196421215">
         <span class="h2">
          Thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A hypercoagulable state resulting in arterial and venous thromboses is common in critically ill patients with COVID-19. While some studies suggest an incidence as high as 30 percent, the true incidence is unknown. Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability", section on 'ICU'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3696481378">
         <span class="h2">
          Sepsis, shock, multi-organ failure, secondary infections
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sepsis, shock, multi-organ failure
         </strong>
         – In critically ill patients with COVID-19, sepsis, shock, and multi-organ failure occur but appear to be less common compared with non-COVID-19-related ARDS. The need for vasoactive agents is variable. In a cohort study from Wuhan, China, 35 percent of patients received vasoactive agents [
         <a href="#rid2">
          2
         </a>
         ]. In contrast, in a case series from New York City, 95 percent of patients who received mechanical ventilation required vasopressor support [
         <a href="#rid30">
          30
         </a>
         ]. In our experience, hypotension is unusual in the absence of a specific cause, and the need for vasoactive agents is typically driven by sedation medications, cardiac dysfunction, or secondary bacterial infection. (See
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Secondary infections
         </strong>
         – Critically ill patients with COVID-19 are at risk of developing secondary infections, although robust data are limited. Secondary infections include pneumonia (eg, bacterial, fungal), vascular catheter infections, urinary tract infections, Epstein Barr and cytomegalovirus reactivation, and rarely strongyloides reactivation [
         <a href="#rid2">
          2,51-53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Rates vary among studies. As an example, in one retrospective Italian study of 774 critically ill patients with COVID-19, 46 percent had hospital acquired infections, of which one third were multidrug-resistant (MDR) bacteria [
         <a href="#rid52">
          52
         </a>
         ]. Half of hospital acquired infections were ventilator-associated pneumonia (mostly Gram-negative bacteria and
         <em>
          Staphylococcus aureus
         </em>
         ) and one-third were bloodstream infections. As expected, such infections prolonged hospitalization and increased mortality. In contrast, in a cohort of intubated patients from China, hospital-acquired pneumonia, in many cases with resistant pathogens, was reported in 12 percent [
         <a href="#rid2">
          2
         </a>
         ]. Whether rates have increased with the more widespread use of
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         and other immunomodulating agents is unknown.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Several reports have described presumptive invasive aspergillosis among immunocompetent patients with ARDS from COVID-19, although the frequency of this complication is uncertain [
         <a href="#rid54">
          54-58
         </a>
         ]. In one prospective study of 108 patients on mechanical ventilation for COVID-19 in Italy, probable aspergillosis was diagnosed in 30 (28 percent) based on elevated serum or bronchoalveolar lavage (BAL) galactomannan levels, growth of
         <em>
          Aspergillus
         </em>
         on BAL cultures, or a cavitary infiltrate without other cause [
         <a href="#rid57">
          57
         </a>
         ]. Another registry study reported that 2 percent of COVID-19 patients had proven invasive
         <em>
          Aspergillus
         </em>
         , while 14 percent had probable infection and 3 percent had possible infection [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Cases of mucormycosis have also been reported, primarily from India, among critically ill and other hospitalized patients with COVID-19. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2465.html" rel="external">
          "Mucormycosis (zygomycosis)", section on 'Coronavirus disease 2019-associated'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Similarly, cases of reactivated strongyloides have also been described, which is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5714.html" rel="external">
          "Strongyloidiasis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H137313171">
         <span class="h2">
          Pneumothorax and barotrauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pneumothorax can occur in critically ill patients with COVID-19 who are spontaneously breathing or mechanically ventilated [
         <a href="#rid2">
          2,59-66
         </a>
         ]. Patients with COVID-19-related ARDS on mechanical ventilation may be at increased risk of barotrauma compared with other patients with ARDS, although data are variable with rates ranging from 2 to 40 percent. Rates may be higher in patients receiving invasive ventilation compared with noninvasive ventilation, and those on invasive ventilation are at an increased risk of death compared with non-COVID-19 patients with barotrauma [
         <a href="#rid62">
          62,65,66
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6706.html" rel="external">
          "Pneumothorax in adults: Epidemiology and etiology", section on 'Necrotizing lung infections'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">
          "Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H68238330">
         <span class="h1">
          LABORATORY FINDINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory findings in critically ill patients with COVID-19 include leukopenia or leukocytosis, lymphopenia, and elevated D-dimer, aminotransferases, lactate dehydrogenase, and ferritin levels. Although these can also be seen with less severe COVID-19, the abnormalities are typically more profound in critically ill patients [
         <a href="#rid1">
          1,3,29
         </a>
         ]. Critically ill patients with COVID-19 may also have an elevated procalcitonin level. (See
         <a class="medical medical_review" href="/z/d/html/114753.html" rel="external">
          "Procalcitonin use in lower respiratory tract infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Laboratory findings'
         </a>
         .)
        </p>
        <p>
         Some patients with severe COVID-19 have laboratory evidence of an exuberant inflammatory response, similar to cytokine release syndrome (CRS), with persistent fevers, elevated inflammatory markers (eg, D-dimer, ferritin, interleukin-6 [IL-6]), and elevated proinflammatory cytokines (eg, IL-6 and tumor necrosis factor [TNF]); these laboratory abnormalities have been associated with poor prognosis [
         <a href="#rid67">
          67
         </a>
         ]. However, some studies suggest that the elevated levels of proinflammatory cytokines associated with critical COVID-19 are lower than those in patients with septic shock [
         <a href="#rid68">
          68
         </a>
         ]. Rare cases of hemophagocytic lymphohistiocytosis (HLH) have also been described [
         <a href="#rid69">
          69
         </a>
         ]. Further details regarding CRS and HLH are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/118012.html" rel="external">
          "Cytokine release syndrome (CRS)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87499.html" rel="external">
          "Clinical features and diagnosis of hemophagocytic lymphohistiocytosis"
         </a>
         .)
        </p>
        <p>
         The presence of antiphospholipid antibodies has also been described; however, they are mostly of the IgA subclass, and the clinical significance is unclear [
         <a href="#rid70">
          70
         </a>
         ]. Abnormal coagulation parameters which are commonly seen in COVID-19 patients (eg, elevated D-dimer, prolonged prothrombin time) are also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability", section on 'Evaluation of atypical laboratory findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4678.html" rel="external">
          "Diagnosis of antiphospholipid syndrome"
         </a>
         .)
        </p>
        <p>
         Data suggest that measuring procalcitonin (PCT) or C-reactive protein (CRP) upon admission to identify bacterial superinfection is not useful [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2354063484">
         <span class="h1">
          IMAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical imaging findings do not appear to be different in mild or severe cases of COVID-19 (eg, ground-glass opacification with or without consolidative abnormalities, consistent with viral pneumonia, minimal or no pleural effusions) [
         <a href="#rid2">
          2,72-79
         </a>
         ]. Chest radiography, computed tomography, and lung ultrasonography findings are described separately. (See
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Imaging findings'
         </a>
         .)
        </p>
        <p>
         Our approach to bedside ultrasonography is similar to that of other critically ill patients [
         <a href="#rid80">
          80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14867.html" rel="external">
          "Indications for bedside ultrasonography in the critically ill adult patient"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2192719700">
         <span class="h1">
          PATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The lung pathology of COVID-19 pneumonia in critically ill patients remains under study. The pathology in most patients appears consistent with that of acute respiratory distress syndrome (ARDS).
        </p>
        <p>
         Most autopsy reports describe hyaline membrane changes and microvessel thrombosis suggestive of early ARDS (ie, exudative and proliferative phases of diffuse alveolar damage [DAD]) [
         <a href="#rid81">
          81-92
         </a>
         ]. Other findings include bacterial pneumonia (isolated or superimposed on DAD) and viral pneumonitis [
         <a href="#rid84">
          84,88
         </a>
         ]. Less common findings include acute fibrinous organizing pneumonia (AFOP; in the late stages) [
         <a href="#rid93">
          93
         </a>
         ], amyloid deposition in the heart and lung, and rarely alveolar hemorrhage and vasculitis [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease", section on 'Diffuse alveolar damage'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">
          "Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults", section on 'Pathologic diagnosis and stages'
         </a>
         .)
        </p>
        <p>
         Evidence of pulmonary thrombosis and thromboembolism has also been reported in autopsy series [
         <a href="#rid84">
          84,88,89,94
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability"
         </a>
         .)
        </p>
        <p>
         Distant organ involvement has also been seen with the demonstration of virus in organs other than the lung and, in some cases, acute tubular necrosis and a generalized thrombotic microangiopathy in the kidney [
         <a href="#rid84">
          84,88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/127552.html" rel="external">
          "COVID-19: Issues related to acute kidney injury, glomerular disease, and hypertension"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3836701352">
         <span class="h1">
          PROGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3394835130">
         <span class="h2">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several retrospective studies have reported variable mortality from COVID-19-related acute respiratory distress syndrome (ARDS) [
         <a href="#rid1">
          1-3,15-18,26,28,29,32,33,35-37,95-102
         </a>
         ]. Mortality appears lower than that in patients with severe acute respiratory syndrome (SARS-CoV-1) or Middle East respiratory syndrome (MERS). The mortality from COVID-19 appears driven by the presence of severe ARDS, and ranges widely, from 12 to 78 percent with an average of 25 to 50 percent. However, death can occur from several other conditions including cardiac arrythmia, cardiac arrest, and pulmonary embolism. Limited data suggest that among those with ARDS, there is no difference in mortality between those who have COVID-19-related ARDS and those with non-COVID-19-related ARDS [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p>
         In resource-limited settings, mortality may be on the higher end of this range. One study of nearly 4000 patients from 64 intensive care units (ICUs) in 10 African countries reported a 30-day mortality of 48 percent [
         <a href="#rid101">
          101
         </a>
         ]. Mortality ranged from 43 percent for patients referred from the emergency department to 51 percent in patients transferred from another facility.
        </p>
        <p>
         Mortality may be changing as the pandemic progresses [
         <a href="#rid15">
          15,19,37,99,103-106
         </a>
         ]. In an analysis of patients during a resurgence of COVID-19 in Houston, Texas, in-hospital mortality was lower during the second surge compared with the first surge (5 versus 12 percent) but the difference in ICU mortality was not significant (23 versus 28 percent) [
         <a href="#rid15">
          15
         </a>
         ]. In another French cohort of over 4000 critically ill patients, mortality decreased from 42 to 25 percent over a four-month period during the pandemic [
         <a href="#rid99">
          99
         </a>
         ]. In a United States analysis of 468 patients with COVID-19-related critical illness from March 1, 2020 to May 11, 2020, the mortality decreased from 44 to 19 percent [
         <a href="#rid37">
          37
         </a>
         ]. Another US single-center analysis of three consecutive surges reported between March 2020 and December 2020 a similar reduction between surge 1 and surge 2 (29 percent versus 25 percent) [
         <a href="#rid106">
          106
         </a>
         ]. However, mortality was highest in the third surge (35 percent). Changes in mortality may be reflective of different patient populations, altered comorbidity burdens, staffing burdens of institutions, and/or growing expertise with COVID-19 care. However, reported rates may not accurately reflect differences in practice patterns over the course of the pandemic (eg, early versus late timing of intubation, increasing use of noninvasive modalities).
        </p>
        <p class="headingAnchor" id="H2624566620">
         <span class="h2">
          Risk factors for death
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, the consistent major risk factor associated with death in critically ill patients with COVID-19 is older age (≥64 years) [
         <a href="#rid2">
          2,3,11,12,14,17,18,26,28,36,97,99-101,107-109
         </a>
         ]. In one study of over two thousand critically ill patients, age ≥80 years was associated with and 11-fold increased risk of death [
         <a href="#rid109">
          109
         </a>
         ]. Other risk factors associated with death among critically ill patients include the following [
         <a href="#rid2">
          2,3,6,9,11,14,17,26,28,29,33,97,99,109-117
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The development of ARDS, particularly severe ARDS, and the need for mechanical ventilation
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comorbidities (eg, obesity, chronic cardiac and pulmonary conditions, hypertension, diabetes, chronic kidney disease, renal replacement therapy, cancer)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Markers of inflammation or coagulation (eg, fever, D-dimer level &gt;1 microg/mL admission, elevated fibrin degradation products, prolonged activated partial thromboplastin and prothrombin times)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Select laboratory studies (eg, worsening lymphopenia, neutrophilia, troponin elevation)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Male sex
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severity of organ dysfunction on admission
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Right ventricular dysfunction
        </p>
        <p>
        </p>
        <p>
         In resource-limited settings, risk factors for death were similar but also included HIV infection (odds ratio [OR] 1.9) and delay in admission due to resource limitations (OR 2.0) [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
         The rapidity of symptom progression does not appear to predict a worse outcome [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         While high fever was associated with a higher likelihood of developing ARDS (hazard ratio [HR] 1.77, 95% CI 1.11-2.84), it appears to be associated with a lower likelihood of death (HR 0.41, 95% CI 0.21-0.82) [
         <a href="#rid2">
          2,28
         </a>
         ], a phenomenon that has been noted previously in non-COVID-19-related critical illness. (See
         <a class="medical medical_review" href="/z/d/html/1624.html" rel="external">
          "Fever in the intensive care unit", section on 'Outcomes'
         </a>
         .)
        </p>
        <p>
         It is unclear whether vaccination decreases the risk of death in critically ill intubated patients with conflicting data on this issue [
         <a href="#rid118">
          118,119
         </a>
         ].
        </p>
        <p>
         Several prognostic models have been proposed but none is clearly superior nor accurately predicts deterioration or mortality to a great degree [
         <a href="#rid120">
          120,121
         </a>
         ]. The preintubation sequential organ assessment score has been shown to perform poorly as a predictor of death in patients with COVID-19 [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H373510088">
         <span class="h2">
          Length of stay
         </span>
         <span class="headingEndMark">
          —
         </span>
         Length of ICU stay and mechanical ventilation is prolonged for patients with COVID-19-related ARDS compared with non-COVID-19-related ARDS, with many COVID-19 patients remaining intubated for at least one to two weeks or longer [
         <a href="#rid17">
          17,123,124
         </a>
         ]. In one retrospective review of 148 patients with COVID-19 the mean time to discontinuation of mechanical ventilation was 33 days and length of stay 55 days [
         <a href="#rid125">
          125
         </a>
         ]. However, the number of days free of mechanical ventilation and length of ICU stay may have improved since the introduction of effective directed therapies for COVID-19 [
         <a href="#rid126">
          126
         </a>
         ]. However, in resource-limited settings, one study reported a mean length of stay of seven days, which may reflect a difference in practice given the limitations at such facilities. Readmission rates among those who have recovered from COVID-19 are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">
          "COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4081381983">
         <span class="h2">
          Long-term sequelae
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prolonged symptoms are common during recovery from critical illness due to COVID-19, and many patients suffer from post-acute COVID-19 syndrome (PACS). PACS shares overlapping symptoms with post intensive care syndrome (PICS), which is a syndrome that many patients experience after discharge from the ICU. In our experience, the rate of long-term complications in critically ill patients with COVID-19 may be higher than usual due to the prolonged nature of intubation and higher use of neuromuscular blockade and sedatives, with or without concurrent glucocorticoid administration. Long-term sequelae that can be seen in patients with COVID-19, including outcomes in tracheostomized patients, and evaluation for and management of PICS are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">
          "COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88330.html" rel="external">
          "Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3633341158">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/126613.html" rel="external">
          "Society guideline links: COVID-19 – Index of guideline topics"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3114544931">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (See
         <a class="medical medical_basics" href="/z/d/html/126678.html" rel="external">
          "Patient education: COVID-19 overview (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/130329.html" rel="external">
          "Patient education: COVID-19 vaccines (The Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H307136816">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rates of ICU admission
         </strong>
         – Patients with coronavirus disease 2019 (COVID-19) can become critically ill, typically due to the development of acute respiratory distress syndrome (ARDS) and/or complications of the disease. Among patients hospitalized with COVID-19, up to one-quarter require intensive care unit (ICU) admission representing 5 to 8 percent of the total infected population. However, rates of ICU admission vary, reflecting differences in practice, admission criteria, and population characteristics in the region served by the ICU. Rates may change as the pandemic progresses. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – Patients who are critically ill with COVID-19 initially present with similar symptoms to those with mild or moderate illness (eg, fever and cough). Onset of dyspnea is relatively late (median 6.5 days after symptom onset), but progression to ARDS with profound hypoxemic respiratory failure can be swift thereafter. Age appears to be the major risk factor that predicts progression to ARDS. A proportion require mechanical ventilation but the rate varies among ICUs (20 to 100 percent). (See
         <a class="local">
          'Clinical features in critically ill patients'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – Patients may also present with the features associated with the complications of COVID-19. Common complications include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute kidney injury (AKI; one third or more) (see
         <a class="local">
          'Acute kidney injury'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/127552.html" rel="external">
          "COVID-19: Issues related to acute kidney injury, glomerular disease, and hypertension", section on 'Acute kidney injury'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Elevated liver enzymes and other gastrointestinal complications (two-thirds or more) (see
         <a class="local">
          'Gastrointestinal complications'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/129171.html" rel="external">
          "COVID-19: Gastrointestinal symptoms and complications"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Delirium/encephalopathy (two-thirds) (see
         <a class="local">
          'Neurologic complications'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/128153.html" rel="external">
          "COVID-19: Neurologic complications and management of neurologic conditions"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiac injury (one-third) (see
         <a class="local">
          'Cardiac injury'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/129342.html" rel="external">
          "COVID-19: Cardiac manifestations in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127551.html" rel="external">
          "COVID-19: Arrhythmias and conduction system disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127533.html" rel="external">
          "COVID-19: Myocardial infarction and other coronary artery disease issues"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Thrombosis (see
         <a class="local">
          'Thrombosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/127926.html" rel="external">
          "COVID-19: Hypercoagulability", section on 'ICU'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Less common complications include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sepsis, shock, multi-organ failure, secondary infections (see
         <a class="local">
          'Sepsis, shock, multi-organ failure, secondary infections'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1613.html" rel="external">
          "Evaluation and management of suspected sepsis and septic shock in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pneumothorax or barotrauma (see
         <a class="local">
          'Pneumothorax and barotrauma'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">
          "Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory and imaging findings
         </strong>
         – In critically ill patients with COVID-19, laboratory findings include leukopenia or leukocytosis, lymphopenia, and elevated D-dimer, aminotransferases, lactate dehydrogenase, and ferritin; procalcitonin can be elevated as well. Chest imaging findings (predominantly bilateral peripherally distributed ground-glass opacification with or without consolidation) are similar to those seen in less severe illness. (See
         <a class="local">
          'Laboratory findings'
         </a>
         above and
         <a class="local">
          'Imaging'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Laboratory findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">
          "COVID-19: Clinical features", section on 'Imaging findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lung pathology
         </strong>
         – The majority of patients who are critically ill due to COVID-19 have lung pathology consistent with ARDS (ie, diffuse alveolar damage). A small proportion have bacterial pneumonia, acute fibrinous organizing pneumonia, amyloid deposition, hemorrhage, or vasculitis. (See
         <a class="local">
          'Pathology'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease", section on 'Diffuse alveolar damage'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">
          "Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults", section on 'Pathologic diagnosis and stages'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – For critically ill patients with COVID-19, the prognosis is poor with mortality ranging from 25 to 50 percent that is largely driven by severe ARDS. However, death can occur from several other conditions including cardiac arrythmia, cardiac arrest, and pulmonary embolism. The highest rates of death occur in those ≥64 years. As the pandemic progresses, mortality may be decreasing for several reasons. Length of stay appears to be longer than that in patients with non-COVID-19-related ARDS. Long-term sequelae may also be higher in this population. (See
         <a class="local">
          'Prognosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">
          "COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang X, Yu Y, Xu J, at al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020; 323:1061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young BE, Ong SWX, Kalimuddin S, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA 2020; 323:1488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020; 133:1025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368:m1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahase E. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care. BMJ 2020; 368:m1201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020; 323:1239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; 323:2052.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA 2020; 323:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA 2020; 323:1335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020; 323:1612.
          </a>
         </li>
         <li class="breakAll">
          United States Centers for Disease Control and Prevention. Morbidity and mortality weekly report: Severe outcomes among patients with coronavirus disease 2019 (COVID-19) — United States, February 12 – March 16, 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm?s_cid=mm6912e2_w (Accessed on March 19, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vahidy FS, Drews AL, Masud FN, et al. Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area. JAMA 2020; 324:998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med 2020; 382:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 323:1574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murthy S, Archambault PM, Atique A, et al. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study. CMAJ Open 2021; 9:E181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurtz P, Bastos LSL, Dantas LF, et al. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med 2021; 47:538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garg S, Patel K, Pham H, et al. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study. Ann Intern Med 2021; 174:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383:2603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021; 384:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackey K, Ayers CK, Kondo KK, et al. Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med 2021; 174:362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nau C, Bruxvoort K, Navarro RA, et al. COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization. Ann Intern Med 2021; 174:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson MR, Geleris J, Anderson DR, et al. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study. Ann Intern Med 2020; 173:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020; 180:934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goyal P, Choi JJ, Pinheiro LC, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020; 382:2372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. JAMA 2020; 323:2195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020; 369:m1985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369:m1966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020; 369:m1996.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalili M, Payandemehr P, Saghaei A, et al. Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study. Ann Intern Med 2021; 174:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chand S, Kapoor S, Orsi D, et al. COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center. J Intensive Care Med 2020; 35:963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anesi GL, Jablonski J, Harhay MO, et al. Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States. Ann Intern Med 2021; 174:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gabarre P, Dumas G, Dupont T, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 2020; 46:1339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cummings MJ, Baldwin MR, Abrams D, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020; 395:1763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           He XW, Lai JS, Cheng J, et al. [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients]. Zhonghua Xin Xue Guan Bing Za Zhi 2020; 48:456.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatla A, Mayer MM, Adusumalli S, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm 2020; 17:1439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Moheb M, Naar L, Christensen MA, et al. Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19. JAMA 2020; 324:1899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med 2020; 382:2268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020; 77:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pleasure SJ, Green AJ, Josephson SA. The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines. JAMA Neurol 2020; 77:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology 2020; 296:E119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med 2020; 382:2574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Creel-Bulos C, Hockstein M, Amin N, et al. Acute Cor Pulmonale in Critically Ill Patients with Covid-19. N Engl J Med 2020; 382:e70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayek SS, Brenner SK, Azam TU, et al. In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study. BMJ 2020; 371:m3513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Wilton A, Nabarro LE, Godbole GS, et al. Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19. Travel Med Infect Dis 2021; 40:101981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasselli G, Scaravilli V, Mangioni D, et al. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest 2021; 160:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naendrup JH, Garcia Borrega J, Eichenauer DA, et al. Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients. J Intensive Care Med 2022; 37:1152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 associated pulmonary aspergillosis. Mycoses 2020; 63:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaize M, Mayaux J, Nabet C, et al. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient. Emerg Infect Dis 2020; 26:1636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Arkel ALE, Rijpstra TA, Belderbos HNA, et al. COVID-19-associated Pulmonary Aspergillosis. Am J Respir Crit Care Med 2020; 202:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis 2021; 73:e3606.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prattes J, Wauters J, Giacobbe DR, et al. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med 2021; 47:1158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGuinness G, Zhan C, Rosenberg N, et al. Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation. Radiology 2020; 297:E252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Udi J, Lang CN, Zotzmann V, et al. Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study. J Intensive Care Med 2021; 36:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn MR, Watson RL, Thetford JT, et al. High Incidence of Barotrauma in Patients With Severe Coronavirus Disease 2019. J Intensive Care Med 2021; 36:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajdev K, Spanel AJ, McMillan S, et al. Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non-Invasive Positive Pressure Ventilation. J Intensive Care Med 2021; 36:1013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gabrielli M, Valletta F, Franceschi F, Gemelli Against COVID 2019. Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits. Br J Hosp Med (Lond) 2021; 82:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta VK, Alkandari BM, Mohammed W, et al. Ventilator associated lung injury in severe COVID-19 pneumonia patients - Case Reports: Ventilator associated lung injury in COVID-19. Eur J Radiol Open 2021; 8:100310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belletti A, Todaro G, Valsecchi G, et al. Barotrauma in Coronavirus Disease 2019 Patients Undergoing Invasive Mechanical Ventilation: A Systematic Literature Review. Crit Care Med 2022; 50:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melhorn J, Achaiah A, Conway FM, et al. Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the United Kingdom (POETIC) survey. Eur Respir J 2022; 60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395:1033.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kox M, Waalders NJB, Kooistra EJ, et al. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions. JAMA 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dewaele K, Claeys R. Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection. Blood 2020; 135:2323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 2020; 382:e38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galli F, Bindo F, Motos A, et al. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients. Intensive Care Med 2023; 49:934.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simpson S, Kay F, Abbara S, Bhalla S et.. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology 2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao W, Zhong Z, Xie X, et al. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol 2020; 214:1072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernheim A, Mei X, Huang M, et al. Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection. Radiology 2020; 295:200463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ 2020; 368:m1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bao C, Liu X, Zhang H, et al. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. J Am Coll Radiol 2020; 17:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubin GD, Ryerson CJ, Haramati LB, et al. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Radiology 2020; 296:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Y, Dong C, Hu Y, et al. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology 2020; 296:E55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ojha V, Mani A, Pandey NN, et al. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol 2020; 30:6129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johri AM, Galen B, Kirkpatrick JN, et al. ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic. J Am Soc Echocardiogr 2020; 33:670.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Gao Y, Qiao L, et al. Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19). Ann Intern Med 2020; 173:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8:420.
          </a>
         </li>
         <li class="breakAll">
          https://www.medrxiv.org/content/10.1101/2020.04.06.20050575v1 (Accessed on April 29, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med 2020; 173:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barton LM, Duval EJ, Stroberg E, et al. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol 2020; 153:725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang H, Zhou P, Wei Y, et al. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19. Ann Intern Med 2020; 172:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tian S, Hu W, Niu L, et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. J Thorac Oncol 2020; 15:700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menter T, Haslbauer JD, Nienhold R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020; 77:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaller T, Hirschbühl K, Burkhardt K, et al. Postmortem Examination of Patients With COVID-19. JAMA 2020; 323:2518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fox SE, Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020; 8:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. Lancet 2020; 396:320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Copin MC, Parmentier E, Duburcq T, et al. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med 2020; 46:1124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lax SF, Skok K, Zechner P, et al. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series. Ann Intern Med 2020; 173:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA 2020; 323:1499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziehr DR, Alladina J, Petri CR, et al. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study. Am J Respir Crit Care Med 2020; 201:1560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J 2020; 55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasselli G, Greco M, Zanella A, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020; 180:1345.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021; 47:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chew MS, Blixt PJ, Åhman R, et al. National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study. Eur J Anaesthesiol 2021; 38:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study. Lancet 2021; 397:1885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sjoding MW, Admon AJ, Saha AK, et al. Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome. Ann Am Thorac Soc 2021; 18:1876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia 2020; 75:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doidge JC, Gould DW, Ferrando-Vivas P, et al. Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland. Am J Respir Crit Care Med 2021; 203:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Docherty AB, Mulholland RH, Lone NI, et al. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. Lancet Respir Med 2021; 9:773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Auld SC, Harrington KRV, Adelman MW, et al. Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges. Crit Care Med 2022; 50:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xie J, Tong Z, Guan X, et al. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open 2020; 3:e205619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta S, Hayek SS, Wang W, et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med 2020; 180:1436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18:844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020; 55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choron RL, Butts CA, Bargoud C, et al. Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients. J Intensive Care Med 2021; 36:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020; 323:1775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kragholm K, Andersen MP, Gerds TA, et al. Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)-A Danish Nationwide, Register-based Study. Clin Infect Dis 2021; 73:e4025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peckham H, de Gruijter NM, Raine C, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 2020; 11:6317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCall PJ, Willder JM, Stanley BL, et al. Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study. Anaesthesia 2022; 77:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McErlane J, McCall P, Willder J. Cardiac Biomarkers and Right Ventricular Dysfunction Are Associated Independently With 1-Year Mortality in Patients With COVID-19 Receiving Mechanical Ventilation: A Prospective Cohort Study. Chest 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grapsa E, Adamos G, Andrianopoulos I, et al. Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome. JAMA Netw Open 2022; 5:e2235219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grasselli G, Zanella A, Carlesso E, et al. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy. JAMA Netw Open 2022; 5:e2238871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study. Eur Respir J 2020; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raschke RA, Agarwal S, Rangan P, et al. Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation. JAMA 2021; 325:1469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keller MB, Wang J, Nason M, et al. Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage Algorithms. Crit Care Med 2022; 50:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bain W, Yang H, Shah FA, et al. COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes. Ann Am Thorac Soc 2021; 18:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saad M, Laghi FA Jr, Brofman J, et al. Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease 2019. Crit Care Med 2022; 50:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwak PE, Connors JR, Benedict PA, et al. Early Outcomes From Early Tracheostomy for Patients With COVID-19. JAMA Otolaryngol Head Neck Surg 2021; 147:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomazini BM, Maia IS, Cavalcanti AB, et al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA 2020; 324:1307.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 131224 Version 18.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31986264" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32031570" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32125362" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32044814" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32217556" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32209544" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32091533" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32320003" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32109013" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Clinical Characteristics of Coronavirus Disease 2019 in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32167538" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32181795" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Coronavirus Disease 2019 (COVID-19) in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32191259" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32191259" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32789492" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227758" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32250385" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33688026" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33852032" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34370517" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33301246" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33378609" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33253040" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33872046" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32105632" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32171076" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32726151" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32167524" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32007143" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32302078" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clinical Characteristics of Covid-19 in New York City.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32329797" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32444460" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32444366" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32471884" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32687717" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32812834" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33460330" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32533197" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Acute kidney injury in critically ill patients with COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32291094" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32442528" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32171190" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : [Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32585191" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : COVID-19 and cardiac arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32970139" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Gastrointestinal Complications in Critically Ill Patients With and Without COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32294339" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Neurologic Features in Severe SARS-CoV-2 Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32275288" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32275291" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32228363" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32302082" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Guillain-BarréSyndrome Associated with SARS-CoV-2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32374956" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Acute Cor Pulmonale in Critically Ill Patients with Covid-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32998872" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33535106" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33857475" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Hospital-Acquired Infections in Critically Ill Patients With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34791940" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32339350" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : COVID-19 associated pulmonary aspergillosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32343223" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32396381" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : COVID-19-associated Pulmonary Aspergillosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32719848" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34269853" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32614258" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32959730" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33722090" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : High Incidence of Barotrauma in Patients With Severe Coronavirus Disease 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34013825" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Pulmonary Barotrauma in COVID-19 Patients With ARDS on Invasive and Non-Invasive Positive Pressure Ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34191558" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Barotrauma during non-invasive ventilation for acute respiratory distress syndrome caused by COVID-19: a balance between risks and benefits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33364262" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Ventilator associated lung injury in severe COVID-19 pneumonia patients - Case Reports: Ventilator associated lung injury in COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34637421" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Barotrauma in Coronavirus Disease 2019 Patients Undergoing Invasive Mechanical Ventilation: A Systematic Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35144988" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the United Kingdom (POETIC) survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32192578" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : COVID-19: consider cytokine storm syndromes and immunosuppression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32880615" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32556137" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32268022" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37507573" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32125873" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32077789" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32217624" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Managing mental health challenges faced by healthcare workers during covid-19 pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32283052" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32255413" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32191587" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32474632" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32503704" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : ASE Statement on Point-of-Care Ultrasound during the 2019 Novel Coronavirus Pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32282871" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32085846" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32085846" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32374815" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32275742" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : COVID-19 Autopsies, Oklahoma, USA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32163542" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32114094" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32364264" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32437596" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32437497" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Postmortem Examination of Patients With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32473124" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32682491" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32328726" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32422076" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32159735" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Care for Critically Ill Patients With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32348678" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32269088" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32667669" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33211135" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33534266" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34022988" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33577740" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Comparing Clinical Features and Outcomes in Mechanically Ventilated Patients with COVID-19 and Acute Respiratory Distress Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32602561" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33306946" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34000238" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34259667" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32125452" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32275319" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32667668" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32073213" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32217650" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33317374" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32203977" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32634827" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)-A Danish Nationwide, Register-based Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33298944" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35607911" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Right ventricular dysfunction in patients with COVID-19 pneumonitis whose lungs are mechanically ventilated: a multicentre prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Cardiac Biomarkers and Right Ventricular Dysfunction Are Associated Independently With 1-Year Mortality in Patients With COVID-19 Receiving Mechanical Ventilation: A Prospective Cohort Study
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36205996" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36301541" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32978307" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33595630" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35302957" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Preintubation Sequential Organ Failure Assessment Score for Predicting COVID-19 Mortality: External Validation Using Electronic Health Record From 86 U.S. Healthcare Systems to Appraise Current Ventilator Triage Algorithms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33544045" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34407039" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Long-Term Acute Care Hospital Outcomes of Mechanically Ventilated Patients With Coronavirus Disease 2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33331855" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Early Outcomes From Early Tracheostomy for Patients With COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32876695" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
